39 related articles for article (PubMed ID: 22175271)
1. One-year Thyroglobulin Levels as a Predictive Measure for Recurrence and Need for Continued Surveillance in Treated Differentiated Thyroid Cancer.
Herman AE; Argersinger DP; Maksutova M; Morgan T; Hughes DT
Endocr Pract; 2024 Feb; 30(2):89-94. PubMed ID: 37926368
[TBL] [Abstract][Full Text] [Related]
2. Predicting clinical outcomes of patients with serum thyroglobulin antibodies after thyroidectomy for differentiated thyroid cancer: a retrospective study from a UK regional center.
Anderson H; Lim KH; Gull S; Oprean R; Spence K; Cvasciuc T
Minerva Endocrinol (Torino); 2024 Mar; 49(1):60-68. PubMed ID: 37428110
[TBL] [Abstract][Full Text] [Related]
3. In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation.
Zavala LF; Barra MI; Olmos R; Tuttle M; González H; Droppelmann N; Mosso L; Domínguez JM
Arch Endocrinol Metab; 2019; 63(3):293-299. PubMed ID: 31038590
[TBL] [Abstract][Full Text] [Related]
4. The effect of positive thyroglobulin antibodies on the prognosis and treatment response in patients with papillary thyroid carcinoma.
Sanjari M; Ordooei M; Amirkhosravi L; Naghibzadeh-Tahami A; Nazemi S
Heliyon; 2024 Feb; 10(4):e26092. PubMed ID: 38384522
[TBL] [Abstract][Full Text] [Related]
5. Value of follow-up diagnostic radioiodine scans in differentiated thyroid cancer.
Kraus T; Shengelia-de Lange N; Einspieler H; Hacker M; Haug A; Kretschmer-Chott E; Karanikas G
Endocr Connect; 2024 May; 13(5):. PubMed ID: 38513355
[TBL] [Abstract][Full Text] [Related]
6. False diagnosis of recurrent thyroid carcinoma: the importance of testing for heterophile antibodies.
Guastapaglia L; Chiamolera MI; Viana Lima Junior J; Ferrer CMF; Godoy Viana L; Veiga Chang C; Andrade Siqueira R; Monteiro Barros Maciel R; Henriques Vieira JG; Biscolla RPM
Arch Endocrinol Metab; 2024 Mar; 68():e230115. PubMed ID: 38456952
[TBL] [Abstract][Full Text] [Related]
7. Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study.
Wu J; Hu X; Seal P; Amin P; Diederichs B; Paschke R
Eur Thyroid J; 2023 Aug; 12(5):. PubMed ID: 37439446
[TBL] [Abstract][Full Text] [Related]
8. Unstimulated highly sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: a meta-analysis.
Giovanella L; Treglia G; Sadeghi R; Trimboli P; Ceriani L; Verburg FA
J Clin Endocrinol Metab; 2014 Feb; 99(2):440-7. PubMed ID: 24285679
[TBL] [Abstract][Full Text] [Related]
9. Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later.
Melo M; Costa G; Ribeiro C; Carrilho F; Martins MJ; da Rocha AG; Sobrinho-Simões M; Carvalheiro M; Soares P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4364-72. PubMed ID: 24037891
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of treatment efficacy in intermediate-risk thyroid cancer.
Abiri A; Nguyen T; Goshtasbi K; Torabi SJ; Kuan EC; Armstrong WB; Tjoa T; Haidar YM
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2525-2533. PubMed ID: 36651960
[TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with high thyroglobulin level following radioactive iodine ablation, measured 12 months after treatment for papillary thyroid carcinoma.
Kim EY; Hyun KH; Park YL; Park CH; Yun JS
Ann Surg Treat Res; 2017 Jan; 92(1):1-8. PubMed ID: 28090499
[TBL] [Abstract][Full Text] [Related]
12. Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients.
Castagna MG; Cantara S; Pacini F
J Endocrinol Invest; 2016 Oct; 39(10):1087-94. PubMed ID: 27350556
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.
Lamartina L; Montesano T; Trulli F; Attard M; Torlontano M; Bruno R; Meringolo D; Monzani F; Tumino S; Ronga G; Maranghi M; Biffoni M; Filetti S; Durante C
Endocrine; 2016 Nov; 54(2):467-475. PubMed ID: 26668060
[TBL] [Abstract][Full Text] [Related]
14. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
[TBL] [Abstract][Full Text] [Related]
15. Value of repeat stimulated thyroglobulin testing in patients with differentiated thyroid carcinoma considered to be free of disease in the first year after ablation.
Rosario PW; Furtado MS; Mineiro Filho AF; Lacerda RX; Calsolari MR
Thyroid; 2012 May; 22(5):482-6. PubMed ID: 22175271
[TBL] [Abstract][Full Text] [Related]
16. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
[TBL] [Abstract][Full Text] [Related]
17. Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence.
Rosario PW; Furtado Mde S; Mineiro Filho AF; Lacerda RX; Calsolari MR
Thyroid; 2012 Nov; 22(11):1165-9. PubMed ID: 23050784
[TBL] [Abstract][Full Text] [Related]
18. Value of postoperative thyroglobulin and ultrasonography for the indication of ablation and ¹³¹I activity in patients with thyroid cancer and low risk of recurrence.
Rosario PW; Xavier AC; Calsolari MR
Thyroid; 2011 Jan; 21(1):49-53. PubMed ID: 20954820
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
